Lise Lotte Gluud

Summary

Affiliation: Copenhagen Trial Unit
Country: Denmark

Publications

  1. ncbi Bias in clinical intervention research
    Lise Lotte Gluud
    Copenhagen Trial Unit, Center for Clinical Intervention Research, Cochrane Hepato Biliary Group, Rigshospitalet, DK 2100 Copenhagen, Denmark
    Am J Epidemiol 163:493-501. 2006
  2. ncbi [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?]
    Bodil E Als-Nielsen
    H S Rigshospitalet, Center for Klinisk Interventionsforskning, Copenhagen Trial Unit
    Ugeskr Laeger 166:1676-8. 2004
  3. ncbi [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]
    Bodil E Als-Nielsen
    H:S Rigshospitalet, Copenhagen Trial Unit, Center for Klinisk Interventionsforskning
    Ugeskr Laeger 167:179-82. 2005
  4. ncbi Evidence based diagnostics
    Christian Gluud
    Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, H:S Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark
    BMJ 330:724-6. 2005
  5. ncbi Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews
    Sarah Louise Klingenberg
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Gastroenterol Hepatol 26:649-56. 2011
  6. ncbi Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis
    Goran Bjelakovic
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    JAMA 297:842-57. 2007
  7. ncbi [Independent research should be supported]
    Bodil Als-Nielsen
    Ugeskr Laeger 165:4237; author reply 4237-8. 2003
  8. ncbi Unravelling industry bias in clinical trials
    Lise Lotte Gluud
    Pain 121:175-6. 2006
  9. ncbi Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
    Lesley Wood
    Department of Social Medicine, University of Bristol, Bristol BS8 2PR
    BMJ 336:601-5. 2008

Collaborators

Detail Information

Publications9

  1. ncbi Bias in clinical intervention research
    Lise Lotte Gluud
    Copenhagen Trial Unit, Center for Clinical Intervention Research, Cochrane Hepato Biliary Group, Rigshospitalet, DK 2100 Copenhagen, Denmark
    Am J Epidemiol 163:493-501. 2006
    ..A-priori exclusion of trials with certain characteristics is not recommended. Appraising bias control in individual trials is necessary to avoid making incorrect conclusions about intervention effects...
  2. ncbi [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?]
    Bodil E Als-Nielsen
    H S Rigshospitalet, Center for Klinisk Interventionsforskning, Copenhagen Trial Unit
    Ugeskr Laeger 166:1676-8. 2004
  3. ncbi [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]
    Bodil E Als-Nielsen
    H:S Rigshospitalet, Copenhagen Trial Unit, Center for Klinisk Interventionsforskning
    Ugeskr Laeger 167:179-82. 2005
  4. ncbi Evidence based diagnostics
    Christian Gluud
    Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, H:S Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark
    BMJ 330:724-6. 2005
  5. ncbi Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews
    Sarah Louise Klingenberg
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Gastroenterol Hepatol 26:649-56. 2011
    ..In this overview, we present the growth of The CHBG Controlled Trials Register, as well as the systematic reviews that have been produced since March 1996...
  6. ncbi Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis
    Goran Bjelakovic
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    JAMA 297:842-57. 2007
    ..Antioxidant supplements are used for prevention of several diseases...
  7. ncbi [Independent research should be supported]
    Bodil Als-Nielsen
    Ugeskr Laeger 165:4237; author reply 4237-8. 2003
  8. ncbi Unravelling industry bias in clinical trials
    Lise Lotte Gluud
    Pain 121:175-6. 2006
  9. ncbi Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
    Lesley Wood
    Department of Social Medicine, University of Bristol, Bristol BS8 2PR
    BMJ 336:601-5. 2008
    ..To examine whether the association of inadequate or unclear allocation concealment and lack of blinding with biased estimates of intervention effects varies with the nature of the intervention or outcome...